Prostatic Adenoma
|
disease |
Male Urogenital Diseases
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Tuberculosis, Central Nervous System
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Solitary Pulmonary Nodule
|
disease |
Respiratory Tract Diseases
|
Neoplastic Process
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Extensively Drug-Resistant Tuberculosis
|
phenotype |
Infections
|
Disease or Syndrome
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Bile duct proliferation
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
30
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Central nervous system lesion
|
disease |
|
Disease or Syndrome
|
34
|
1
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Myocardial infarction, stroke
|
disease |
|
Disease or Syndrome
|
46
|
3
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Intraductal papillary mucinous neoplasm
|
disease |
|
Neoplastic Process
|
50
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Body Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
57
|
92
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Tuberculosis, Multidrug-Resistant
|
disease |
Infections
|
Disease or Syndrome
|
67
|
8
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hip circumference
|
phenotype |
|
Clinical Attribute
|
68
|
116
|
0.100 |
None |
1.000 |
2 |
2
|
2015 |
2017 |
Tuberculosis, Meningeal
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
68
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Prostatic Diseases
|
group |
Male Urogenital Diseases
|
Disease or Syndrome
|
72
|
4
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
CUI: |
C0860659 |
Disease: |
Aloof
|
Aloof
|
disease |
|
Mental or Behavioral Dysfunction
|
81
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Early gastric cancer
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
100
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cancer cachexia
|
disease |
|
Neoplastic Process
|
110
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
High-Grade Prostatic Intraepithelial Neoplasia
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
111
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Toxoplasmosis
|
disease |
Infections
|
Disease or Syndrome
|
112
|
|
0.010 |
None |
< 0.001 |
1 |
|
2012 |
2012 |
Atherothrombosis
|
disease |
|
Acquired Abnormality
|
115
|
15
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Adenomatous Polyps
|
disease |
Neoplasms
|
Neoplastic Process
|
120
|
20
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Biliary Tract Cancer
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
167
|
11
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Skin Carcinogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
194
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
MRSA - Methicillin resistant Staphylococcus aureus infection
|
disease |
Infections
|
Disease or Syndrome
|
222
|
1
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
Skin Erosion
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
225
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cerebral Palsy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
241
|
69
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |